FDA Approved: ONDANSETRON — Supplemental Application (Eugia US LLC)

View source ↗

Summary

FDA approved a supplemental ANDA from Eugia US LLC for ondansetron hydrochloride (ondansetron), establishing a generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting
• Postoperative Nausea and Vomiting
• Radiation-induced Nausea and Vomiting

Drugs mentioned

• Ondansetron hydrochloride (ondansetron hydrochloride)

Snippet

SUPPL AP for ONDANSETRON (ONDANSETRON HYDROCHLORIDE)